0 XP   0   0   0

SMS PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell SMS PHARMACEUTICALS LTD.?

I guess you are interested in SMS PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse SMS PHARMACEUTICALS LTD.

Let's start. I'm going to help you getting a better view of SMS PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is SMS PHARMACEUTICALS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how SMS PHARMACEUTICALS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value SMS PHARMACEUTICALS LTD.. The closing price on 2023-02-03 was INR74.40 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
SMS PHARMACEUTICALS LTD. Daily Candlestick Chart
SMS PHARMACEUTICALS LTD. Daily Candlestick Chart
Summary









1. Valuation of SMS PHARMACEUTICALS LTD.




Current price per share

INR74.40

2. Growth of SMS PHARMACEUTICALS LTD.




Is SMS PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$57.3m$50m$7.2m12.7%

How much money is SMS PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$7.5m$7.6m-$37.4k-0.5%
Net Profit Margin12.0%11.1%--

How much money comes from the company's main activities?

3. Financial Health of SMS PHARMACEUTICALS LTD.




Comparing to competitors in the Other industry




  Industry Rankings (Other)  


Richest
#264 / 441

Most Revenue
#256 / 441

Most Profit
#198 / 441

Most Efficient
#137 / 441


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of SMS PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit SMS PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • A Net Profit Margin of 12.0% means that ₹0.12 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 12.0%. The company is making a huge profit. +2
  • The TTM is 12.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.0%TTM12.0%0.0%
TTM12.0%YOY11.1%+0.9%
TTM12.0%5Y9.2%+2.7%
5Y9.2%10Y7.7%+1.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0%8.2%+3.8%
TTM12.0%7.4%+4.6%
YOY11.1%7.3%+3.8%
5Y9.2%6.7%+2.5%
10Y7.7%6.6%+1.1%
1.1.2. Return on Assets

Shows how efficient SMS PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • 7.2% Return on Assets means that SMS PHARMACEUTICALS LTD. generated ₹0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 7.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY7.7%-0.5%
TTM7.2%5Y6.7%+0.5%
5Y6.7%10Y6.5%+0.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2%1.0%+6.2%
TTM7.2%1.0%+6.2%
YOY7.7%0.9%+6.8%
5Y6.7%0.9%+5.8%
10Y6.5%0.9%+5.6%
1.1.3. Return on Equity

Shows how efficient SMS PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • 13.2% Return on Equity means SMS PHARMACEUTICALS LTD. generated ₹0.13 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 13.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.2%TTM13.2%0.0%
TTM13.2%YOY15.2%-2.0%
TTM13.2%5Y12.2%+1.0%
5Y12.2%10Y12.6%-0.4%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ13.2%3.1%+10.1%
TTM13.2%2.9%+10.3%
YOY15.2%2.6%+12.6%
5Y12.2%2.4%+9.8%
10Y12.6%2.4%+10.2%

1.2. Operating Efficiency of SMS PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient SMS PHARMACEUTICALS LTD. is operating .

  • Measures how much profit SMS PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y9.3%-9.3%
5Y9.3%10Y10.2%-0.8%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.1%-17.1%
TTM-9.1%-9.1%
YOY-9.2%-9.2%
5Y9.3%8.5%+0.8%
10Y10.2%8.5%+1.7%
1.2.2. Operating Ratio

Measures how efficient SMS PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.44 means that the operating costs are ₹1.44 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 1.440. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.440. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.440TTM1.4400.000
TTM1.440YOY1.482-0.042
TTM1.4405Y1.496-0.056
5Y1.49610Y1.605-0.109
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4401.218+0.222
TTM1.4401.189+0.251
YOY1.4821.203+0.279
5Y1.4961.289+0.207
10Y1.6051.314+0.291

1.3. Liquidity of SMS PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if SMS PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.92 means the company has ₹1.92 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 1.919. The company is able to pay all its short-term debts. +1
  • The TTM is 1.919. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.919TTM1.9190.000
TTM1.919YOY1.594+0.325
TTM1.9195Y1.573+0.346
5Y1.57310Y1.370+0.202
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9191.491+0.428
TTM1.9191.465+0.454
YOY1.5941.475+0.119
5Y1.5731.299+0.274
10Y1.3701.286+0.084
1.3.2. Quick Ratio

Measures if SMS PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • A Quick Ratio of 0.55 means the company can pay off ₹0.55 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 0.545. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.545. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.545TTM0.5450.000
TTM0.545YOY0.755-0.210
TTM0.5455Y0.556-0.011
5Y0.55610Y0.502+0.054
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5450.612-0.067
TTM0.5450.602-0.057
YOY0.7550.600+0.155
5Y0.5560.563-0.007
10Y0.5020.552-0.050

1.4. Solvency of SMS PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of SMS PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SMS PHARMACEUTICALS LTD. to Other industry mean.
  • A Debt to Asset Ratio of 0.45 means that SMS PHARMACEUTICALS LTD. assets are financed with 45.3% credit (debt) and the remaining percentage (100% - 45.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 0.453. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.453. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.453TTM0.4530.000
TTM0.453YOY0.495-0.042
TTM0.4535Y0.446+0.006
5Y0.44610Y0.480-0.034
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4530.562-0.109
TTM0.4530.583-0.130
YOY0.4950.586-0.091
5Y0.4460.583-0.137
10Y0.4800.576-0.096
1.4.2. Debt to Equity Ratio

Measures if SMS PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • A Debt to Equity ratio of 82.8% means that company has ₹0.83 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 0.828. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.828. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.828TTM0.8280.000
TTM0.828YOY0.978-0.151
TTM0.8285Y0.811+0.017
5Y0.81110Y0.940-0.129
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8281.244-0.416
TTM0.8281.337-0.509
YOY0.9781.370-0.392
5Y0.8111.439-0.628
10Y0.9401.455-0.515

2. Market Valuation of SMS PHARMACEUTICALS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings SMS PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare SMS PHARMACEUTICALS LTD. to the Other industry mean.
  • A PE ratio of 12.76 means the investor is paying ₹12.76 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The EOD is 10.122. Very good. +2
  • The MRQ is 12.762. Very good. +2
  • The TTM is 12.762. Very good. +2
Trends
Current periodCompared to+/- 
EOD10.122MRQ12.762-2.639
MRQ12.762TTM12.7620.000
TTM12.762YOY16.842-4.080
TTM12.7625Y13.909-1.147
5Y13.90910Y35.551-21.642
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD10.12236.308-26.186
MRQ12.76238.458-25.696
TTM12.76244.588-31.826
YOY16.84248.072-31.230
5Y13.90940.090-26.181
10Y35.55141.443-5.892
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of SMS PHARMACEUTICALS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The MRQ is 12.825. Seems overpriced? -1
  • The TTM is 12.825. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ12.825TTM12.8250.000
TTM12.825YOY8.505+4.320
TTM12.8255Y11.688+1.136
5Y11.68810Y21.700-10.011
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ12.8250.154+12.671
TTM12.8250.050+12.775
YOY8.5050.186+8.319
5Y11.6880.158+11.530
10Y21.7000.155+21.545

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of SMS PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 1.69 means the investor is paying ₹1.69 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of SMS PHARMACEUTICALS LTD.:

  • The EOD is 1.339. Good. +1
  • The MRQ is 1.688. Good. +1
  • The TTM is 1.688. Good. +1
Trends
Current periodCompared to+/- 
EOD1.339MRQ1.688-0.349
MRQ1.688TTM1.6880.000
TTM1.688YOY2.565-0.877
TTM1.6885Y1.746-0.058
5Y1.74610Y4.332-2.586
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD1.3391.411-0.072
MRQ1.6881.419+0.269
TTM1.6881.575+0.113
YOY2.5651.352+1.213
5Y1.7461.288+0.458
10Y4.3321.330+3.002
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of SMS PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.0607.0600%7.359-4%5.092+39%6.173+14%
Book Value Growth--1.1461.1460%1.179-3%1.131+1%1.102+4%
Book Value Per Share--55.55655.5560%48.496+15%43.365+28%36.688+51%
Book Value Per Share Growth--1.1461.1460%1.179-3%1.131+1%1.102+4%
Current Ratio--1.9191.9190%1.594+20%1.573+22%1.370+40%
Debt To Asset Ratio--0.4530.4530%0.495-8%0.446+1%0.480-6%
Debt To Equity Ratio--0.8280.8280%0.978-15%0.811+2%0.940-12%
Dividend Per Share--0.3000.3000%-+100%0.258+16%0.245+22%
Eps--7.3507.3500%7.3860%5.390+36%4.635+59%
Eps Growth--0.9950.9950%1.980-50%1.228-19%1.216-18%
Free Cash Flow Per Share--1.5341.5340%-7.241+572%-0.311+120%0.668+130%
Free Cash Flow Per Share Growth--2.2122.2120%-18.282+927%-3.034+237%-1.207+155%
Free Cash Flow To Equity Per Share--0.7160.7160%3.629-80%0.986-27%0.782-8%
Free Cash Flow To Equity Per Share Growth--0.1970.1970%7.664-97%1.176-83%3.700-95%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---31.473--------
Intrinsic Value_10Y_min---25.441--------
Intrinsic Value_1Y_max--0.525--------
Intrinsic Value_1Y_min--0.510--------
Intrinsic Value_3Y_max---1.227--------
Intrinsic Value_3Y_min---1.109--------
Intrinsic Value_5Y_max---6.359--------
Intrinsic Value_5Y_min---5.609--------
Net Profit Margin--0.1200.1200%0.111+8%0.092+30%0.077+55%
Operating Margin----0%-0%0.093-100%0.102-100%
Operating Ratio--1.4401.4400%1.482-3%1.496-4%1.605-10%
Pb Ratio1.339-26%1.6881.6880%2.565-34%1.746-3%4.332-61%
Pe Ratio10.122-26%12.76212.7620%16.842-24%13.909-8%35.551-64%
Peg Ratio--12.82512.8250%8.505+51%11.688+10%21.700-41%
Price Per Share74.400-26%93.80093.8000%124.400-25%76.150+23%138.695-32%
Price To Total Gains Ratio10.109-26%12.74512.7450%16.905-25%13.995-9%21.372-40%
Profit Growth--0.9950.9950%1.980-50%1.228-19%1.216-18%
Quick Ratio--0.5450.5450%0.755-28%0.556-2%0.502+9%
Return On Assets--0.0720.0720%0.077-6%0.067+8%0.065+11%
Return On Equity--0.1320.1320%0.152-13%0.122+8%0.126+5%
Revenue Growth--0.9230.9230%1.367-32%1.043-12%1.015-9%
Total Gains Per Share--7.3607.3600%7.359+0%5.351+38%6.418+15%
Total Gains Per Share Growth--1.0001.0000%2.039-51%1.235-19%1.099-9%
Usd Book Value--57375209.20057375209.2000%50084416.000+15%44785182.520+28%37889750.111+51%
Usd Book Value Change Per Share--0.0860.0860%0.090-4%0.062+39%0.075+14%
Usd Book Value Per Share--0.6780.6780%0.592+15%0.529+28%0.448+51%
Usd Dividend Per Share--0.0040.0040%-+100%0.003+16%0.003+22%
Usd Eps--0.0900.0900%0.0900%0.066+36%0.057+59%
Usd Free Cash Flow--1584328.6001584328.6000%-7478063.200+572%-320879.520+120%-178266.400+111%
Usd Free Cash Flow Per Share--0.0190.0190%-0.088+572%-0.004+120%0.008+130%
Usd Free Cash Flow To Equity Per Share--0.0090.0090%0.044-80%0.012-27%0.010-8%
Usd Price Per Share0.908-26%1.1441.1440%1.518-25%0.929+23%1.692-32%
Usd Profit--7590827.8007590827.8000%7628281.8000%5566093.840+36%4786820.467+59%
Usd Revenue--63424664.60063424664.6000%68707655.000-8%59164456.320+7%61976132.844+2%
Usd Total Gains Per Share--0.0900.0900%0.090+0%0.065+38%0.078+15%
 EOD+3 -2MRQTTM+0 -0YOY+19 -215Y+27 -1410Y+31 -10

3.2. Fundamental Score

Let's check the fundamental score of SMS PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.122
Price to Book Ratio (EOD)Between0-11.339
Net Profit Margin (MRQ)Greater than00.120
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.545
Current Ratio (MRQ)Greater than11.919
Debt to Asset Ratio (MRQ)Less than10.453
Debt to Equity Ratio (MRQ)Less than10.828
Return on Equity (MRQ)Greater than0.150.132
Return on Assets (MRQ)Greater than0.050.072
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of SMS PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.985
Ma 20Greater thanMa 5078.408
Ma 50Greater thanMa 10081.422
Ma 100Greater thanMa 20085.230
OpenGreater thanClose74.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets8,595,017
Total Liabilities3,892,131
Total Stockholder Equity4,702,886
 As reported
Total Liabilities 3,892,131
Total Stockholder Equity+ 4,702,886
Total Assets = 8,595,017

Assets

Total Assets8,595,017
Total Current Assets3,770,511
Long-term Assets3,770,511
Total Current Assets
Cash And Cash Equivalents 345,828
Short-term Investments 120,000
Net Receivables 485,193
Inventory 2,554,374
Other Current Assets 773
Total Current Assets  (as reported)3,770,511
Total Current Assets  (calculated)3,506,168
+/- 264,343
Long-term Assets
Property Plant Equipment 4,476,253
Intangible Assets 13,701
Long-term Assets Other 43,006
Long-term Assets  (as reported)4,824,506
Long-term Assets  (calculated)4,532,960
+/- 291,546

Liabilities & Shareholders' Equity

Total Current Liabilities1,964,803
Long-term Liabilities1,927,328
Total Stockholder Equity4,702,886
Total Current Liabilities
Short-term Debt 679,122
Short Long Term Debt 1,106,122
Accounts payable 728,578
Other Current Liabilities 26,809
Total Current Liabilities  (as reported)1,964,803
Total Current Liabilities  (calculated)2,540,631
+/- 575,828
Long-term Liabilities
Long term Debt Total 1,516,159
Capital Lease Obligations 31,548
Long-term Liabilities  (as reported)1,927,328
Long-term Liabilities  (calculated)1,547,707
+/- 379,621
Total Stockholder Equity
Common Stock84,652
Retained Earnings 3,920,050
Capital Surplus 698,184
Total Stockholder Equity (as reported)4,702,886
Total Stockholder Equity (calculated)4,702,886
+/-0
Other
Capital Stock84,652
Cash and Short Term Investments 465,828
Common Stock Shares Outstanding 84,652
Liabilities and Stockholders Equity 8,595,017
Net Debt 2,135,309
Net Invested Capital 7,304,023
Net Working Capital 1,805,708



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
5,092,695
5,412,172
4,679,173
4,931,523
5,025,262
5,588,143
6,079,146
8,122,128
8,595,017
8,595,0178,122,1286,079,1465,588,1435,025,2624,931,5234,679,1735,412,1725,092,695
   > Total Current Assets 
2,155,422
2,027,922
1,363,153
1,573,563
1,684,870
2,075,903
2,187,809
3,093,289
3,770,511
3,770,5113,093,2892,187,8092,075,9031,684,8701,573,5631,363,1532,027,9222,155,422
       Cash And Cash Equivalents 
120,502
63,637
100,000
171,744
126,308
147,977
95,442
404,231
345,828
345,828404,23195,442147,977126,308171,744100,00063,637120,502
       Short-term Investments 
0
0
0
0
0
0
0
4,483
120,000
120,0004,4830000000
       Net Receivables 
908,996
990,660
208,248
493,807
455,939
517,059
678,570
1,056,798
485,193
485,1931,056,798678,570517,059455,939493,807208,248990,660908,996
       Inventory 
904,738
860,205
734,805
925,193
1,074,753
1,363,998
1,292,002
1,403,594
2,554,374
2,554,3741,403,5941,292,0021,363,9981,074,753925,193734,805860,205904,738
       Other Current Assets 
216,328
106,241
897
27,568
21,401
36,406
103,105
867
773
773867103,10536,40621,40127,568897106,241216,328
   > Long-term Assets 
0
0
0
4,123,159
3,340,392
3,512,240
3,891,337
5,028,840
4,824,506
4,824,5065,028,8403,891,3373,512,2403,340,3924,123,159000
       Property Plant Equipment 
2,857,076
3,056,179
3,030,642
2,977,983
2,870,955
2,984,092
3,217,760
4,625,044
4,476,253
4,476,2534,625,0443,217,7602,984,0922,870,9552,977,9833,030,6423,056,1792,857,076
       Long Term Investments 
58,727
132,281
205,104
291,245
0
0
0
0
0
00000291,245205,104132,28158,727
       Intangible Assets 
2,208
3,512
4,023
4,160
3,627
11,488
8,326
16,024
13,701
13,70116,0248,32611,4883,6274,1604,0233,5122,208
       Long-term Assets Other 
0
0
0
0
0
0
0
56,328
43,006
43,00656,3280000000
> Total Liabilities 
2,874,665
2,864,572
2,395,376
2,384,078
2,180,375
2,368,969
2,596,790
4,016,848
3,892,131
3,892,1314,016,8482,596,7902,368,9692,180,3752,384,0782,395,3762,864,5722,874,665
   > Total Current Liabilities 
1,911,907
1,655,533
1,301,103
1,469,956
1,214,574
1,425,496
1,452,076
1,940,931
1,964,803
1,964,8031,940,9311,452,0761,425,4961,214,5741,469,9561,301,1031,655,5331,911,907
       Short-term Debt 
1,669,986
1,670,829
674,112
597,596
583,971
708,086
611,552
708,586
679,122
679,122708,586611,552708,086583,971597,596674,1121,670,8291,669,986
       Short Long Term Debt 
1,669,986
1,670,829
2,041,609
1,757,037
747,317
848,086
840,702
708,586
1,106,122
1,106,122708,586840,702848,086747,3171,757,0372,041,6091,670,8291,669,986
       Accounts payable 
504,874
513,024
752,698
615,681
326,919
421,742
395,506
654,402
728,578
728,578654,402395,506421,742326,919615,681752,698513,024504,874
       Other Current Liabilities 
327,775
174,151
222,912
23,273
53,228
108,151
141,371
81,934
26,809
26,80981,934141,371108,15153,22823,273222,912174,151327,775
   > Long-term Liabilities 
0
0
0
1,456,091
965,801
910,972
1,144,714
2,075,917
1,927,328
1,927,3282,075,9171,144,714910,972965,8011,456,091000
       Long term Debt Total 
0
0
892,722
742,154
713,982
622,105
730,009
1,518,988
1,516,159
1,516,1591,518,988730,009622,105713,982742,154892,72200
       Capital Lease Obligations 
0
0
0
0
0
0
47,799
40,635
31,548
31,54840,63547,799000000
> Total Stockholder Equity
2,218,030
2,547,600
2,283,797
2,547,445
2,844,887
3,219,174
3,482,356
4,105,280
4,702,886
4,702,8864,105,2803,482,3563,219,1742,844,8872,547,4452,283,7972,547,6002,218,030
   Common Stock
100,152
84,652
84,652
84,652
84,652
84,652
84,652
84,652
84,652
84,65284,65284,65284,65284,65284,65284,65284,652100,152
   Retained Earnings 
1,419,694
1,749,264
1,500,961
1,749,109
2,046,551
2,420,838
2,684,020
3,322,444
3,920,050
3,920,0503,322,4442,684,0202,420,8382,046,5511,749,1091,500,9611,749,2641,419,694
   Capital Surplus 
0
0
698,184
698,184
698,184
698,184
698,184
698,184
698,184
698,184698,184698,184698,184698,184698,184698,18400
   Treasury Stock000000000
   Other Stockholders Equity 
15,500
15,500
15,500
15,500
15,500
15,500
15,500
0
0
0015,50015,50015,50015,50015,50015,50015,500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue5,198,743
Cost of Revenue-3,159,917
Gross Profit2,038,8262,038,826
 
Operating Income (+$)
Gross Profit2,038,826
Operating Expense-4,325,468
Operating Income821,805-2,286,642
 
Operating Expense (+$)
Research Development-
Selling General Administrative895,496
Selling And Marketing Expenses-
Operating Expense4,325,468895,496
 
Net Interest Income (+$)
Interest Income147,290
Interest Expense-181,566
Net Interest Income-186,043-34,276
 
Pretax Income (+$)
Operating Income821,805
Net Interest Income-186,043
Other Non-Operating Income Expenses-
Income Before Tax (EBT)684,991821,805
EBIT - interestExpense = -181,566
622,199
803,765
Interest Expense181,566
Earnings Before Interest and Taxes (ebit)-866,557
Earnings Before Interest and Taxes (ebitda)1,188,082
 
After tax Income (+$)
Income Before Tax684,991
Tax Provision-6,182
Net Income From Continuing Ops622,199678,809
Net Income622,199
Net Income Applicable To Common Shares622,199
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-186,043
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ENLT.TA
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENLT.TA.

ENLT.TA Daily Candlestick Chart
GBPEUR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPEUR.FOREX.

GBPEUR.FOREX Daily Candlestick Chart
NZDPHP.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDPHP.FOREX.

NZDPHP.FOREX Daily Candlestick Chart
NZDIDR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NZDIDR.FOREX.

NZDIDR.FOREX Daily Candlestick Chart
MYRGBP.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRGBP.FOREX.

MYRGBP.FOREX Daily Candlestick Chart
GBPMYR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPMYR.FOREX.

GBPMYR.FOREX Daily Candlestick Chart
GBPIDR.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPIDR.FOREX.

GBPIDR.FOREX Daily Candlestick Chart
SGDGBP.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGDGBP.FOREX.

SGDGBP.FOREX Daily Candlestick Chart
GBPSGD.FOREX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GBPSGD.FOREX.

GBPSGD.FOREX Daily Candlestick Chart
CADNOK.FOREX
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CADNOK.FOREX.

CADNOK.FOREX Daily Candlestick Chart
SVRT.TA
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVRT.TA.

SVRT.TA Daily Candlestick Chart
PHTM.TA
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHTM.TA.

PHTM.TA Daily Candlestick Chart
NICE.TA
6 hours ago

I found you a Golden Cross on the daily chart of NICE.TA.

NICE.TA Daily Candlestick Chart
NFTA.TA
6 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
ICB.TA
6 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ICB.TA.

ICB.TA Daily Candlestick Chart
FRSX.TA
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FRSX.TA.

FRSX.TA Daily Candlestick Chart
DCMA.TA
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DCMA.TA.

DCMA.TA Daily Candlestick Chart
ARD.TA
6 hours ago

I found you a Death Cross on the daily chart of ARD.TA.

ARD.TA Daily Candlestick Chart
MCRNT.TA
8 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart